S&P 500
(-0.71%) 4 975.36 points
Dow Jones
(0.28%) 37 882 points
Nasdaq
(-1.64%) 15 345 points
Oil
(0.37%) $83.04
Gas
(-0.40%) $1.750
Gold
(0.43%) $2 408.30
Silver
(1.07%) $28.69
Platinum
(-1.14%) $943.60
USD/EUR
(-0.04%) $0.939
USD/NOK
(-0.08%) $11.03
USD/GBP
(0.39%) $0.807
USD/RUB
(-0.90%) $93.05

Realtime updates for Captor Therapeutics [CTX.WA]

Exchange: WSE Sector: Healthcare Industry: Biotechnology
Last Updated19 Apr 2024 @ 11:00

-2.67% PLN 80.20

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:00):

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases...

Stats
Today's Volume 409.00
Average Volume 2 609.00
Market Cap 372.59M
EPS PLN0 ( 2023-11-28 )
Last Dividend PLN0 ( N/A )
Next Dividend PLN0 ( N/A )
P/E -5.28
ATR14 PLN0.579 (0.72%)

Captor Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Captor Therapeutics Financials

Annual 2022
Revenue: PLN9.16M
Gross Profit: PLN7.07M (77.21 %)
EPS: PLN-8.02
Q3 2023
Revenue: PLN2.81M
Gross Profit: PLN1.05M (37.46 %)
EPS: PLN-3.72
Q2 2023
Revenue: PLN2.36M
Gross Profit: PLN2.52M (106.87 %)
EPS: PLN-6.91
Q1 2023
Revenue: PLN1.54M
Gross Profit: PLN1.11M (71.94 %)
EPS: PLN-3.09

Financial Reports:

No articles found.

Captor Therapeutics

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators